ImmunityBio (IBRX)

Infacell Therapeutics, Inc. • Inex Bio, Inc. • NantCell, Inc. • Etubics Corporation • Altor BioScience, LLC • Altor BioScience Manufacturing Company, LLC • Receptome, Inc. • VBC Holdings LLC • GlobeImmune, Inc. • Immunotherapy NANTibody, LLC ...

IBRX stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$18.00

Low target

$6.00

High target

$30.00

Latest filings (excl ownership)

View all

8-K

Departure of Directors or Certain Officers

12 Feb 25

8-K

Departure of Directors or Certain Officers

7 Feb 25

424B5

Prospectus supplement for primary offering

12 Dec 24

8-K

ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock

11 Dec 24

8-K

ImmunityBio, Inc. Announces Proposed Public Offering of Common Stock

10 Dec 24

424B5

Prospectus supplement for primary offering

10 Dec 24

8-K

ImmunityBio Completes ANKTIVA’s Post-Approval Enrollment of the 100th Patient in

12 Nov 24

ImmunityBio Reports Third-Quarter 2024 Financial Results

12 Aug 24

Latest ownership filings

View all

Financial summary

Financial statements Chart IBRX financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	111.97 mm	111.97 mm	111.97 mm	111.97 mm	111.97 mm	111.97 mm
Cash burn (monthly)	6.05 mm	5.50 mm	28.58 mm	48.99 mm	32.92 mm	35.11 mm
Cash used (since last report)	30.72 mm	27.95 mm	145.24 mm	248.95 mm	167.28 mm	178.42 mm
Cash remaining	81.24 mm	84.02 mm	-33.28 mm	-136.98 mm	-55.32 mm	-66.46 mm
Runway (months of cash)	13.4	15.3	-1.2	-2.8	-1.7	-1.9

Beta Read what these cash burn values mean

Financial data from ImmunityBio earnings reports.

Institutional ownership, Q4 2024

IBRX institutional ownership history Ownership history

51.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	201	182	+10.4%
Opened positions	44	26	+69.2%
Closed positions	25	37	-32.4%
Increased positions	70	62	+12.9%
Reduced positions	42	40	+5.0%

13F shares	Current	Prev Q	Change
Total value	210.46 bn	252.66 bn	-16.7%
Total shares	374.24 mm	360.31 mm	+3.9%
Total puts	2.25 mm	1.31 mm	+71.7%
Total calls	1.02 mm	1.68 mm	-39.1%
Total put/call ratio	2.2	0.8	+182.1%

Largest owners	Shares	Value	Change
Cambridge Equities	291.69 mm	$1.46 bn	0.0%
Vanguard	17.33 mm	$44.36 bn	+2.5%
BlackRock	13.58 mm	$34.78 bn	+14.6%
STT State Street	9.79 mm	$25.05 bn	+13.1%
MS Morgan Stanley	4.01 mm	$10.25 bn	+78.3%
Geode Capital Management	3.84 mm	$9.83 bn	-0.1%
Woodline Partners	3.44 mm	$8.81 bn	+682.7%
Cormorant Asset Management	3.00 mm	$7.68 bn	NEW
Tang Capital Management	2.81 mm	$7.20 bn	NEW
UBS UBS	1.59 mm	$4.06 bn	+290.6%

Largest transactions	Shares	Bought/sold	Change
Woodline Partners	3.44 mm	+3.00 mm	+682.7%
Cormorant Asset Management	3.00 mm	+3.00 mm	NEW
Tang Capital Management	2.81 mm	+2.81 mm	NEW
BAC Bank of America	260.73 k	-1.81 mm	-87.4%
MS Morgan Stanley	4.01 mm	+1.76 mm	+78.3%
BlackRock	13.58 mm	+1.73 mm	+14.6%
Ubs Global Asset Management Americas	261.73 k	-1.28 mm	-83.1%
Perceptive Advisors	1.22 mm	+1.22 mm	NEW
UBS UBS	1.59 mm	+1.18 mm	+290.6%
STT State Street	9.79 mm	+1.13 mm	+13.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

IBRX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
22 Feb 25	Soon-shiong Patrick	Common Stock	Payment of exercise	Dispose F	No	No	3.42	42,071	143.88 k	29,546,190
22 Feb 25	Soon-shiong Patrick	Common Stock	Option exercise	Acquire M	No	No	0	114,329	0.00	29,588,261
22 Feb 25	Soon-shiong Patrick	RSU Common Stock	Option exercise	Dispose M	No	No	0	114,329	0.00	228,658
22 Feb 25	David C. Sachs	Common Stock	Payment of exercise	Dispose F	No	No	3.42	15,860	54.24 k	225,620
22 Feb 25	David C. Sachs	Common Stock	Option exercise	Acquire M	No	No	0	40,650	0.00	241,480
22 Feb 25	David C. Sachs	RSU Common Stock	Option exercise	Dispose M	No	No	0	40,650	0.00	81,301
22 Feb 25	Richard Adcock	Common Stock	Payment of exercise	Dispose F	No	No	3.42	78,167	267.33 k	334,418
22 Feb 25	Richard Adcock	Common Stock	Option exercise	Acquire M	No	No	0	152,439	0.00	412,585
22 Feb 25	Richard Adcock	RSU Common Stock	Option exercise	Dispose M	No	No	0	152,439	0.00	304,878
22 Feb 25	Simon Barry J.	Common Stock	Payment of exercise	Dispose F	No	No	3.42	5,453	18.65 k	3,243,571